CUTR - キュテラ （Cutera Inc.） キュテラCUTRのチャート
CUTRの企業情報
| symbol | CUTR |
|---|---|
| 会社名 | Cutera Inc （キュテラ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 キュテラ(Cutera Inc.)は医療機器会社である。同社は世界中の開業医に提供するレーザーおよびその他のエネルギーベース美容システムの設計、開発、製造、マーケティング、サービスを行う。同社は医師や他の開業医が美容整形の実行を可能にするenlighten、excel HR、truSculpt、excel Vとxeoなどを含む製品プラットフォームを提供する。同社の各レーザーと光ベースのプラットフォームは１つまたは複数のハンドピース、及び１つのグラフィック?ユーザー?インターフェース、１つのレーザーや光ベースのモジュール、制御システムソフトウェアおよび高電圧電子機器を内蔵した１つのコンソールで構成される。同社もCV、ExcelとVantageを含むCoolGlide、Titan S、ProWave 770、OPS 600、LP560、AcuTip 500、Titan V/XLとLimeLightを含むSolera、及び日本市場向けの第三者ソースシステムmyQを提供する。 キュテラは、米国の医療機器メ―カ―。レ―ザ―光治療器をはじめとする医療機器の設計、開発、製造、販売、修理などを行う。主な製品は、美容医療治療器｢ゼオ｣、爪水虫治療器｢ジェネシス・プラス｣、部分痩身器｢トゥル―・スカルプ｣など。本社は、カリフォルニア州ブリスベン。 Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. |
| 本社所在地 | 3240 Bayshore Blvd. Brisbane CA 94005 USA |
| 代表者氏名 | J. Daniel Plants J.ダニエル・プラント |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 415-657-5500 |
| 設立年月日 | 36008 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2004年 |
| 従業員数 | 367人 |
| url | www.cutera.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cutr |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 0.92300 |
| 終値（lastsale） | 21.435 |
| 時価総額（marketcap） | 296591808 |
| 時価総額 | 時価総額（百万ドル） 279.22660 |
| 売上高 | 売上高（百万ドル） 162.48300 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 250.22160 |
| 当期純利益 | 当期純利益（百万ドル） 32.76400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Cutera Inc. revenues increased 17% to $76.7M. Net loss totaled $3.6M vs. income of $925K. Revenues reflect United States segment increase of 21% to $49.3M. Net loss reflects Selling General_Admin increase of 21% to $27.5M (expense) General_admin exp increase of 49% to $8.5M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $0.07 to -$0.26. |
CUTRのテクニカル分析
CUTRのニュース
Global Hair Transplant Market Forecast 2021 with Company Analysis of Venus Concept, Sisram Medical, CUTERA, Allergan 2021/06/21 10:45:00 Business Insider Markets
DUBLIN, June 21, 2021 /PRNewswire/ -- The
Dermatology Devices Market Growth, Projections, Analysis, Trends and Forecast 2027| Alma Lasers, Ltd., CuterA 2021/06/18 03:20:42 Jumbo News
LOS ANGELES, United States: The report is a fine example of comprehensive and accurate research study on the global Dermatology Devices market. It digs deep into critical aspects of the global Dermatology Devices market, including market dynamics, competition, regional advancement, and segmentation. It provides verified market figures such as CAGR, market share, revenue, volume, production, []
Cutera Announces Renewal of Distribution Agreement with ZO Skin Health 2021/06/16 20:13:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (Cutera or the Company), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that it has renewed its agreement with ZO Skin Health to be the exclusive distributor of ZOs skincare products in Japan. The initial term of the new agreement spans three years from the effective date of June 15, 2021, with annual renewal options for Cutera in each of the two years following
Laser Hair Removal Market in North America By Laser Type , By End Use and By Country 2020 - 2026 2021/06/16 12:08:00 Intrado Digital Media
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "North America Laser Hair Removal Market By Laser Type (Diode Laser, Nd:YAG Laser and Alexandrite Laser), By End Use (Beauty Clinics, Dermatology Clinics and Home Use), By Country, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com''s offering. The North America Laser Hair Removal Market is expected to witness market growth of 34.4% CAGR during the forecast period (2020-2026). A medical procedure that utilizes a concentrated beam of light (laser) to destroy undesirable hair is known as laser hair removal. A laser emits a light that is absorbed by the pigment (melanin) in the hair at the time of the hair removal process. During this process, the light energy is transformed to heat, which destroys the tube-shaped sacs within the skin (hair follicles) that generate hairs. This damage can limit or delay further hair growth. The procedure of hair removal through exposure to pulses of laser light that eradicate the hair follicle is termed laser hair removal.
InMode Files ITC Complaint Against ILOODA and its U.S. Distributor, Cutera 2021/03/16 11:30:00 PR Newswire
YOKNEAM, Israel, March 16, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has filed a complaint with the United States International Trade Commission ("ITC") alleging ILOODA's SecretRF fractional radio frequency ("RF")…
Cutera, Inc. Announces Pricing of Offering of $125 Million of Convertible Senior Notes 2021/03/05 12:01:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the pricing of $125 million aggregate principal amount of 2.25% convertible senior notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Cutera also granted the initial purchasers of the notes an op
Cutera, Inc. Announces Proposed Private Offering of $125 Million of Convertible Senior Notes 2021/03/03 22:05:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that it intends to offer, subject to market conditions and other factors, $125 million aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Cutera a
Cosmetic Surgery Market to see Huge Growth by 2025: Merz Pharma, Cutera, Bausch Health 2021/02/24 11:15:15 OpenPR
Stay up-to-date and exploit latest trends of Cosmetic Surgery Market with latest edition released by AMA. Cosmetic Surgery Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Cosmetic Surgery industry with an
Cutera, Inc. Announces Fourth Quarter and Full-Year 2020 Financial Results 2021/02/17 21:01:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the fourth quarter and full year ended December 31, 2020. Fourth Quarter 2020 Financial and Operational Highlights Revenue was $49.9 million in the fourth quarter, a decrease of 4% from the prior-year period and an increase of 28% sequentially. The year-over-year decline
InMode Files ITC Complaint Against ILOODA and its U.S. Distributor, Cutera 2021/03/16 11:30:00 PR Newswire
YOKNEAM, Israel, March 16, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has filed a complaint with the United States International Trade Commission ("ITC") alleging ILOODA's SecretRF fractional radio frequency ("RF")…
Cutera, Inc. Announces Pricing of Offering of $125 Million of Convertible Senior Notes 2021/03/05 12:01:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the pricing of $125 million aggregate principal amount of 2.25% convertible senior notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Cutera also granted the initial purchasers of the notes an op
Cutera, Inc. Announces Proposed Private Offering of $125 Million of Convertible Senior Notes 2021/03/03 22:05:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that it intends to offer, subject to market conditions and other factors, $125 million aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Cutera a
Cosmetic Surgery Market to see Huge Growth by 2025: Merz Pharma, Cutera, Bausch Health 2021/02/24 11:15:15 OpenPR
Stay up-to-date and exploit latest trends of Cosmetic Surgery Market with latest edition released by AMA. Cosmetic Surgery Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Cosmetic Surgery industry with an
Cutera, Inc. Announces Fourth Quarter and Full-Year 2020 Financial Results 2021/02/17 21:01:00 Business Wire
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the fourth quarter and full year ended December 31, 2020. Fourth Quarter 2020 Financial and Operational Highlights Revenue was $49.9 million in the fourth quarter, a decrease of 4% from the prior-year period and an increase of 28% sequentially. The year-over-year decline